Goldman Sachs’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,182
| Closed | -$165K | – | 5130 |
|
|
2023
Q2 | $165K | Sell |
1,182
-291
| -20% | -$40.5K | ﹤0.01% | 4453 |
|
|
2023
Q1 | $424K | Sell |
1,473
-8
| -0.5% | -$2.31K | ﹤0.01% | 4161 |
|
|
2022
Q4 | $387K | Hold |
1,481
| – | – | ﹤0.01% | 4217 |
|
|
2022
Q3 | $397K | Hold |
1,481
| – | – | ﹤0.01% | 4385 |
|
|
2022
Q2 | $495K | Hold |
1,481
| – | – | ﹤0.01% | 4384 |
|
|
2022
Q1 | $907K | Hold |
1,481
| – | – | ﹤0.01% | 4173 |
|
|
2021
Q4 | $900K | Sell |
1,481
-190
| -11% | -$115K | ﹤0.01% | 4113 |
|
|
2021
Q3 | $1.64M | Buy |
1,671
+185
| +12% | +$181K | ﹤0.01% | 3632 |
|
|
2021
Q2 | $2.22M | Buy |
1,486
+2
| +0.1% | +$2.99K | ﹤0.01% | 3426 |
|
|
2021
Q1 | $3.99M | Buy |
1,484
+3
| +0.2% | +$8.07K | ﹤0.01% | 2841 |
|
|
2020
Q4 | $2.92M | Sell |
1,481
-76
| -5% | -$150K | ﹤0.01% | 2837 |
|
|
2020
Q3 | $4.2M | Buy |
1,557
+54
| +4% | +$146K | ﹤0.01% | 2492 |
|
|
2020
Q2 | $4.27M | Sell |
1,503
-10
| -0.7% | -$28.4K | ﹤0.01% | 2426 |
|
|
2020
Q1 | $4.04M | Buy |
1,513
+1,450
| +2,302% | +$3.88M | ﹤0.01% | 2380 |
|
|
2019
Q4 | $160K | Buy |
+63
| New | +$160K | ﹤0.01% | 4037 |
|